» Articles » PMID: 29317984

P-glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer's Disease

Overview
Publisher Wiley
Date 2018 Jan 11
PMID 29317984
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

ATP-binding cassette (ABC) transporters, in particular P-glycoprotein (encoded by ABCB1), are important and selective elements of the blood-brain barrier (BBB), and they actively contribute to brain homeostasis. Changes in ABCB1 expression and/or function at the BBB may not only alter the expression and function of other molecules at the BBB but also affect brain environment. Over the last decade, a number of reports have shown that ABCB1 actively mediates the transport of beta amyloid (A) peptide. This finding has opened up an entirely new line of research in the field of Alzheimer's disease (AD). Indeed, despite intense research efforts, AD remains an unsolved pathology and effective therapies are still unavailable. Here, we review the crucial role of ABCB1 in the A transport and how oxidative stress may interfere with this process. A detailed understanding of ABCB1 regulation can provide the basis for improved neuroprotection in AD and also enhanced therapeutic drug delivery to the brain.

Citing Articles

The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.

Kim S, Jung U, Kim S J Clin Med. 2025; 14(2).

PMID: 39860392 PMC: 11765772. DOI: 10.3390/jcm14020386.


How Antiretroviral Drug Concentrations Could Be Affected by Oxidative Stress, Physical Capacities and Genetics: A Focus on Dolutegravir Treated Male PLWH.

Cusato J, Mulasso A, Ferrara M, Manca A, Accardo G, Palermiti A Antioxidants (Basel). 2025; 14(1).

PMID: 39857416 PMC: 11759814. DOI: 10.3390/antiox14010082.


Structural insights into binding-site access and ligand recognition by human ABCB1.

Kurre D, Dang P, Le L, Gadkari V, Alam A EMBO J. 2025; 44(4):991-1006.

PMID: 39806099 PMC: 11833089. DOI: 10.1038/s44318-025-00361-z.


Structural insight into binding site access and ligand recognition by human ABCB1.

Kurre D, Dang P, Le L, Gadkari V, Alam A bioRxiv. 2024; .

PMID: 39185192 PMC: 11343101. DOI: 10.1101/2024.08.12.607598.


Enhancing of cerebral Abeta clearance by modulation of ABC transporter expression: a review of experimental approaches.

Loeffler D Front Aging Neurosci. 2024; 16:1368200.

PMID: 38872626 PMC: 11170721. DOI: 10.3389/fnagi.2024.1368200.


References
1.
Chin J, Soffir R, Noonan K, Choi K, Roninson I . Structure and expression of the human MDR (P-glycoprotein) gene family. Mol Cell Biol. 1989; 9(9):3808-20. PMC: 362442. DOI: 10.1128/mcb.9.9.3808-3820.1989. View

2.
DeMars K, Yang C, Hawkins K, McCrea A, Siwarski D, Candelario-Jalil E . Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats. J Exp Neurosci. 2017; 11:1179069517701741. PMC: 5398227. DOI: 10.1177/1179069517701741. View

3.
Bendayan R, Lee G, Bendayan M . Functional expression and localization of P-glycoprotein at the blood brain barrier. Microsc Res Tech. 2002; 57(5):365-80. DOI: 10.1002/jemt.10090. View

4.
Begley D . Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther. 2004; 104(1):29-45. DOI: 10.1016/j.pharmthera.2004.08.001. View

5.
Olah M, Biber K, Vinet J, Boddeke H . Microglia phenotype diversity. CNS Neurol Disord Drug Targets. 2010; 10(1):108-18. DOI: 10.2174/187152711794488575. View